Solara Active Pharma Sciences is currently trading at Rs. 715.25, up by 35.00 points or 5.15% from its previous closing of Rs. 680.25 on the BSE.
The scrip opened at Rs. 688.90 and has touched a high and low of Rs. 737.00 and Rs. 688.90 respectively. So far 17424 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 737.00 on 24-Feb-2020 and a 52 week low of Rs. 275.10 on 05-Aug-2019.
Last one week high and low of the scrip stood at Rs. 737.00 and Rs. 601.00 respectively. The current market cap of the company is Rs. 1859.82 crore.
The promoters holding in the company stood at 40.14%, while Institutions and Non-Institutions held 23.36% and 36.51% respectively.
United States Food and Drug Administration (USFDA) has completed two successful inspections of Solara Active Pharma Science’s state of the art manufacturing facilities at Puducherry and Mangalore. The inspection established that the two sites are in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The agency with their designated auditors inspected the two facilities from February 17 to 21, 2020.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |